Analyst Research

Report Title Price
Provider: Thomson Reuters Stock Report
$25.00
Provider: S&P Capital IQ – STARS Reports
$115.00
Provider: Pechala's Reports
$15.00
Provider: Reuters Investment Profile
$20.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

WebMD Health Corp. Lowers FY 2012 Guidance; Issues Q3 2012 Guidance; Revenue Guidance Below Analysts' Estimates


Tuesday, 24 Jul 2012 06:45am EDT 

WebMD Health Corp. announced that based on current visibility into the second half of this year, WebMD has updated its financial guidance for fiscal 2012 and expects revenue of $455 million to $480 million, adjusted EBITDA of $60 million to $75 million; and loss from continuing operations of $(12.4) million to $(23.4) million. WebMD's prior financial guidance for fiscal 2012, as last disseminated on May 1, 2012, was: revenue of $500 million to $535 million, adjusted EBITDA of $100 million to $125 million; and net income of $2.8 million to $19.9 million. For the third quarter of 2012, WebMD expects revenue of $115 to $120 million, adjusted EBITDA is expected to be approximately 13% to 15% of revenue; and loss from continuing operations is expected to be approximately 3% to 5% of revenue. According to I/B/E/S Estimates, analysts were expecting the Company to report revenues of $502 million, EBITDA of $105 million and net income of $4.4 million for fiscal 2012; and revenues of $129 million, EBITDA of $30.6 million and net income of $4.09 million for the third quarter of 2012. 

Company Quote

28.67
-1.3 -4.34%
17 Jun 2013